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Summary
Cloning mammals by nuclear transfer (NT) remains
inefficient. One fundamental question is whether
clones have really been derived from differentiated
cells rather than from rare stem cells present in do-
nor-cell samples. To date, cells, such as mature lym-
phocytes, with genetic differentiation markers have
been cloned to generate mice only via a two-step NT
involving embryonic stem (ES) cell generation and
tetraploid complementation [1–3]. Here, we show that
the genome of a unique T-cell population, natural
killer T (NKT) cells, can be fully reprogrammed by a
single-step NT. The pups and their placentas pos-
sessed the rearranged TCR loci specific for NKT cells.
The NKT-cell-cloned embryos had a high develop-
mental potential in vitro: Most (71%) developed to the
morula/blastocyst stage, in marked contrast to em-
bryos from peripheral blood T cells (12%; p < 1 ×
10−25). Furthermore, ES cell lines were efficiently
established from these NKT-cell blastocysts. These
findings clearly indicate a high level of plasticity in
the NKT-cell genome. Thus, differentiation of the ge-
nome is not always a barrier to NT cloning for either
reproductive or therapeutic purposes, so we can now
postulate that at least some mammals cloned to date
have indeed been derived from differentiated donor
cells.
Results and Discussion
NKT-Cell Clones Have High Developmental
Potency In Vitro
Previously, we analyzed the efficiency of somatic-cell
cloning in mice by using two cell types and six geno-
types for donors (2 × 6 factorial analysis of variance
[ANOVA]) and found that immature Sertoli cells with the
(B6 × 129) F1-mouse-strain genotype gave the best re-
sults in terms of birth rates of offspring after embryo
transfer (about 10%) [4]. To extend this result, we sought
cells that retain high genome reprogrammability among
lymphocyte populations from such males. We eventu-
ally found that natural killer T lymphocytes (NKT cells)*Correspondence: ogura@rtc.riken.jp
3 These authors contributed equally to this work.had such potency. NKT cells are small lymphoid cells
that play regulatory roles, such as the inhibition of tu-
mor development, protection against the development
of autoimmune disease, and maintenance of trans-
plantation tolerance [5], in the immune system. Further-
more, it has recently been demonstrated that NKT cells
provide an innate-type immune response to certain gly-
cosphingolipid-bearing microorganisms through re-
cognition by their antigen receptor [6, 7]. We isolated
NKT cells by fluorescence-activated cell sorting (FACS)
of mononuclear cells from the livers of (B6 × 129) F1
male mice and used these for nuclear transfer (NT). NT
was performed by direct injection into enucleated oo-
cytes, as described previously [8]. Peripheral blood
(helper) T cells isolated from the same strain of mice
were used for NT experiments as controls. After 24 hr
in culture, the majority of reconstructed oocytes devel-
oped into 2-cell embryos irrespectively of the cells
used, as expected from their G0 cell-cycle state (Table
1 and Figure 1A). It is known that G0/G1-stage cell-
cycle donors are readily synchronized with oocytes in
this cloning technique [8]. Within the next 24 hr,
whereas many of the T-cell clones arrested their devel-
opment at the 2-cell stage, most NKT-cell clones
reached the 4-cell stage (Table 1 and Figure 1A). More-
over, 71% of NKT-cell-clone embryos developed into
the morulae/blastocyst stage, which was very signifi-
cantly different from the rate of development of T-cell
clones (12%, p < 1 × 10−25) (Table 1 and Figure 1A). This
poor development of T-cell clones in vitro is consistent
with that reported previously by Hochedlinger et al. [1].
However, the developmental potential of NKT-cell-
clone embryos was unexpectedly high. In embryos
constructed by NT, normal embryonic gene activation
occurs only when the donor genome has been repro-
grammed to the zygotic state [9]. For mice, most em-
bryonic gene activation occurs in the early 2-cell stage
[10], and, therefore, embryos that fail to activate their
zygotic genes do not develop beyond this stage. Thus,
the genome of NKT cells appears to be more readily
reprogrammed than that of T cells, at least in terms of
activation of the genes necessary for preimplantation
development.
We further examined the plasticity of the NKT-cell ge-
nome by isolating nuclear-transfer ES cell (NTES cell)
lines from NKT-cell embryos. When these embryos
were harvested under conventional condition for NTES-
cell establishment, six lines were successfully isolated.
This efficiency (4% per 147 reconstructed embryos)
was similar to that reported for clones from cumulus
cells (2.3%–6.9%) or adult fibroblasts (1.1%–3.8%) [11]
and much higher than the rates reported for clones
from lymphocytes (0.2%–0.3%) [1].
The NKT-Cell Genome Supports Full-Term-Embryo
Development by Single-Step Nuclear Transfer
When 272 embryos derived from NKT cells were trans-
ferred into pseudopregnant females, four (1.5%) devel-
oped to term offspring and 13 (4.8%) developed into
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1115Table 1. Development In Vitro and In Vivo of Embryos Cloned from NKT and T Cells
Time in No. No. (%) No. (%) No. (%) No. No. (%) No. (%) No. (%)
Cell Type Culture Cultured Cleaved R 4-Cell M & B* Transferred Implanted Fetuses Placenta-Only
NKT cells
48 hr 280 260 (93) 241 (86) 185 112 (61) 3 (1.6) 5 (2.7)
72 hr 292 274 (94) 241 (83) 207 (71) 87 49 (56) 1 (1.1) 8 (9.2)
T cells
48 hr 105 62 (59) 21 (20) 21 3 (14) 0 (0) 0 (0)
72 hr 232 174 (75) 81 (35) 28 (12) 23 0 (0) 0 (0) 0 (0)
* indicates Morulae and blastocysts. See Figure 1A for statistical analysis.ited the rearranged TCRVa14 locus (Figure 1C). The (Figure 1D). They are currently healthy in appearance at
Figure 1. Development and Southern-Blot
Analysis of NKT Clones
(A) Survival of embryos reconstructed from
nuclei of NKT cells or T cells during in vitro
culture. The data from 48-hr- and 72-hr-cul-
tured groups in Table 1 have been combined.
* indicates p < 0.0001; ** indicates p < 1 ×
10−25.
(B) NKT clones and their placentas at birth.
Clones #1 and #2 were alive and grew into
normal adults (see [D]). Clone #3 was alive
at birth but was cannibalized by its foster
mother. Clone #4 was stillborn. The clones
had placentas that were two to four times
heavier than those of the genotype-matched
intracytoplasmic sperm injection (ICSI) con-
trols.
(C) Southern-blot analysis of the genomic
DNA of NKT-cell-derived cloned mice for the
detection of rearrangements of the TCRVa14
(upper) and TCRVb loci (lower). Black arrow-
heads indicate the nonrearranged bands,
and white arrowheads indicate those that
correspond to the rearranged loci. Genomic-
DNA samples are from C57BL/6 (B6) mouse
tail (lane 1); 129/Sv ES cells (lane 2); donor
F1 (B6 × 129/Sv) mouse tail (lane 3); clone #1 tail (lane 4); clone #1 placenta (lane 5); clone #2 tail (lane 6); clone #2 placenta (lane 7); clone
#3 placenta (lane 8); and clone #4 placenta (lane 9). At the Va14 locus (upper), rearrangement of the B6- and 129-strain alleles is indicated
by the appearance of the 8 kb band and the disappearance of the 2.5 kb band, respectively. Clones #1, #3, and #4 carry a rearranged B6-
strain allele (lanes 4, 5, 8, and 9), whereas clone #2 carries a rearranged 129-strain allele (lanes 6 and 7; note the absence of the 2.5 kb band;
the 8 kb band probably represents an out-of-frame rearrangement of the B6 allele). The 13 kb band for the B6-strain allele persisted after
rearrangement because of the presence of a pseudogene. At the Vb locus (lower), both the B6- and 129-strain alleles have been rearranged,
as indicated by the appearance of two new bands in clones #1, #2, #3, and #4 (lanes 4 and 5, 6 and 7, 8, and 9, respectively). For clones #1
and #2, rearrangement of the TCR loci was also confirmed by sequence analysis (see Figures 2A and 2B).
(D) NKT clones #1 and #2 that grew into adults. They showed a mild obese phenotype which is known to be associated with cumulus-cell
clones [17].placenta-only conceptuses (Table 1 and Figure 1A). All
these 17 clone placentas showed mild or heavy hyper-
plasia (0.15–0.46 g) two to four times larger than the
genotype-matched-control placentas produced by
microinsemination (0.08–0.11 g) (Figure 1B); this is char-
acteristic of the abnormal growth patterns of mouse so-
matic-cell clones [12, 13]. T-cell-clone embryos were
also transferred into recipient females, as described
above, but very few implanted and none survived
through term (Table 1). The T-cell receptor (TCR) reper-
toire in NKT cells is highly restricted to the invariant
Vα14 receptor, which in the mouse is encoded by the
genes Va14–Ja281 and Vb8 [5]. Thus, it is feasible to
trace the NKT donor genome in cloned animals. South-
ern-blot analysis of these clones with specific probes
demonstrated that all clones and their placentas inher-TCRVb locus was also rearranged for both alleles (Fig-
ure 1C). Polymerase chain reaction (PCR) amplification
and DNA sequencing of the rearranged alleles also con-
firmed the clonality of the NKT-cell-cloned mice. Cloned
mouse #1 inherited the rearranged allele of Va14–Ja281
derived from the C57BL/6 strain, whereas that of
cloned mouse #2 was from the 129/Sv lineage (Figure
2A). Similarly, the TCRVb sequences of clones #1 and
#2 had the in-frame configurations Vb8S2-D1-Jb2S5
and Vb8S3-D1-Jb1S4, respectively (Figure 2B). We then
analyzed peripheral blood cells by FACS for the Vβ phe-
notypes of the two NKT clones. In both clones, unlike
the control donor strain, the TCRVβ cells were all posi-
tive for TCRVβ8, clearly demonstrating the occurrence
of allelic exclusion [14] in these cloned mice (Figure
2C). Clones #1 and #2 grew into normal-looking adults
Current Biology
1116Figure 2. DNA-Sequence Analysis of the
TCRV Loci and FACS Analysis of Peripheral
Lymphocytes in NKT Clones
(A) The TCRVa14 DNA sequences. The dot-
dash line indicates polymorphism between
the alleles of the C57BL/6 (B6) and 129
mouse strains. Clones #1 and #4 carry the
rearranged B6-strain allele, whereas clone
#2 carries the rearranged 129-strain allele.
The asterisk indicates the N-position nucleo-
tide that connects Va14 and Ja281. The de-
rived DNA sequences show in-frame re-
arrangements. The bottom line indicates the
amino acid sequence.
(B) The TCRVb DNA sequences. That of
clone #1 consists of the in-frame Vb8S2-D1-
Jb2S5 sequence, whereas that of clone #2
consists of the in-frame Vb8S3-D1-Jb1S4 se-
quence.
(C) FACS analysis of peripheral lymphocytes
in cloned mice. Expression of Vb8 on
TCRVb-positive T cells in the peripheral
blood from the control (B6 × 129), clone #1,
and clone #2 mice. Numbers in circles repre-
sent the percentage of gated lymphocytes.
Disappearance of non-Vb8-expressing T
cells from the TCRVb-carrying population in
the two clones demonstrates exclusive ex-
pression (allelic exclusion) of the Vb8 allele
at the TCRVb locus.the ages of 15 and 11 months, respectively, although p
athey are relatively heavier than normal mice, as re-
ported for mice cloned from cumulus cells [15] (Figure r
a1D). They proved to be fertile, producing litters of off-
spring that have normal numbers (nine to 17 pups per f
clitter) and in which the rearranged alleles have been in-
herited through the germline. These F1 progeny are o
palso fertile and have given birth to F2 mice, some of
which are homozygous for the rearranged alleles, as f
eexpected (data not shown).
p
vNKT-Cell Cloning as a Model
ffor Nuclear-Transfer Studies
sIt has previously been reported that the nuclei of pe-
tripheral lymphocytes and olfactory sensory neurons,
vwhich both express stable markers of differentiated
ocells, can be cloned to generate mice [1–3]. These find-
fings are very clear demonstrations of the reprogramma-
sbility of the differentiated nuclei. However, unlike most
aother clones, these were generated by a two-step NT,
ra technique involving ES-cell generation and tetraploid
gcomplementation to produce a viable placenta [1–3]. In
bthis, the ES-cell stage allows for extra reprogramming
gtime, and tetraploid-cell lines may contribute to most
mextra-embryonic tissues, which are commonly the more
adversely affected components in cloned animals [16].
Furthermore, tetraploid cells rarely contribute to any eart of the embryo proper through term [17]. Eggan et
l. also attempted to produce clones directly from neu-
onal nuclei without tetraploid complementation, but
gain ES-cell intervention was necessary [2]. These
acts leave open the possibility that the “successful”
lones may have been produced by the accidental use
f undifferentiated stem cells [18]. In this paper, we re-
ort the birth of offspring after single-step direct NT
rom NKT cells. The transferred genomes generated
mbryonic as well as extra-embryonic tissues, which
lay essential complementary roles in mammalian de-
elopment. This provides the first direct evidence that
ully differentiated cell nuclei carrying and expressing
pecific genetic markers can be reprogrammed within
he oocyte cytoplasm to support full-term-embryo de-
elopment. Thus, we can postulate that at least some
f the mammals cloned to date are probably derived
rom differentiated donor cells rather than from stray
tem cells. We observed a very high developmental
bility of NKT-cell embryos in vitro (71% of the embryos
eached the morula/blastocyst stage) and efficient
eneration of NKT-ES cells (4% per reconstructed em-
ryos). Thus, certain fully differentiated cells may be a
ood source of donors for reproductive cloning in ani-
als as well as therapeutic cloning in humans.
In mouse NT experiments, cloned offspring are most
fficiently obtained when ES cells are used for donors
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extremely inefficient, and cloning fetal neural cells [20]
is intermediate. Immature Sertoli cells from newborn
males were reported to be better donor cells than cu-
mulus cells, the germline support cells in female adults
[6]. Taken together, these ideas show that it is conceiv-
able that the efficiency (birth rate) of cloning depends
on the state of differentiation of donor cells [21]. How-
ever, we demonstrate here that NKT cells with specific
differentiated markers are suitable donors for the gen-
eration of cloned offspring and NTES-cell lines. Fur-
thermore, although tissue-specific stem cells (e.g.,
hematopoietic cells and neural stem cells) are expected
to be effective donor cells because of their innate dif-
ferential plasticity [21], so far there has been no report
of successful cloning by NT from these cells. Thus, we
speculate that the capacity of the genome to be repro-
grammed by NT is biologically distinct from the degree
of genomic plasticity on the basis of its differentiation
status (or its “stemness,” in reverse). What determines
this potential? Both NKT cells and T cells belong to the
same hematopoietic-cell lineage and undergo similar
DNA rearrangements to express TCR, but attempts to
clone from these lineages show very different effi-
ciency. Examination of the relationship between chro-
matin structure and the efficiency of cloning from dif-
ferent hematopoietic cells, including NKT cells, might
help solve this question.
Experimental Procedures
Preparation of Donor Cells
Male (C57BL/6 × 129/Sv) F1 mice aged 2 to 5 months were used
for the preparation of NKT cells and helper/inducer T cells. For the
collection of NKT cells, we isolated dispersed liver mononuclear
cells by using Percoll density gradients (Amersham Biosciences,
Piscataway, New Jersey), and we sorted NKT cells via a Moflo flow
cytometer (Dako Cytomation, Carpinteria, California) with phyco-
erythrin (PE)-α-galactosylceramide-loaded CD1-D tetramer (pre-
pared in-house) and a fluorescein isothiocyanate (FITC)-labeled
anti-TCRVβ (H57) monoclonal antibody (PharMingen, San Diego,
California). The NKT cells were sorted twice and were more than
99% pure, as assessed by flow cytometry. For the collection of T
cells, we isolated mononuclear cells from peripheral blood and
stained them with PE-conjugated anti-CD3 and allophycocyanin
(APC)-conjugated anti-CD4 monoclonal antibodies (eBioscience,
San Diego, California). CD3+CD4+ helper/inducer T cells were
sorted with a triple-laser flow cytometer, model FACS Vantage SE
(BD Biosciences, San Jose, California). The purity of sorted cells
was determined as more than 98% by flow cytometry. In our pre-
liminary study, we confirmed 97%–99% viability after sorting for
both NKT-cell and T-cell populations by propidium-iodide staining.
Nuclear Transfer
Nuclear transfer was performed as described previously, with
minor modifications [4, 8]. Mature oocytes were collected from su-
perovulated B6D2F1 females and enucleated and injected with
NKT-cell nuclei via a Piezo-driven micromanipulator (Primetech
Corporation, Ibaraki, Japan). The reconstructed oocytes were cul-
tured in KSOM medium [22], and 4-cell embryos (48 hr in culture)
or morulae/blastocysts (72 hr in culture) were transferred into the
oviducts of ICR-strain pseudopregnant females at 0.5 days post
coitus (dpc) with vasectomized males. At 19.5 dpc, the recipient
females were killed and their uteri were examined for live or dead
fetuses. Live fetuses were then reared by lactating ICR-strain foster
mothers. Genotype-matched controls were produced by intracy-
toplasmic sperm injection as previously reported [23].Southern-Blot Analysis
Genomic DNA (4 g from the tail or 20 g from the placenta) was
digested with EcoRI (TCRVa14 probe) or BamHI (TCRVb probe).
The bands were visualized with radiolabeled TCR Va14 and Vb
probes, which were derived from genomic regions 66569–67106
(AE008684) and 163526–164357 (AE000665.1), respectively.
Sequence Analysis
The Va14–Ja281 fragment was amplified with AmpliTaq-Gold
(Roche, Nutley, New Jersey) in a PCR reaction mixture that con-
tained RNase-treated genomic DNA and the primers 5#-GACC
CAAGTGGAGCAGAGTC-3# and 5#-AGGTATGACAATCAGCTGAG
TCC-3#. The PCR products were purified with a PCR Purification
Kit (Qiagen, Tokyo, Japan) and sequenced with a model 3100 Ge-
netic Analyzer (Applied Biosystems/Hitachi, Tokyo, Japan). For
TCRVb sequencing, we used RNase-treated genomic DNA as the
template in the PCR reaction to detect in-frame Vb-D-J fragments.
In brief, we used combinations of primers that corresponded to a
given TCRVb region and that encompassed either the 5# end of the
TCRVbC1 gene or the 3# end of the J b2S7 gene. The PCR products
were sequenced as described above.
Analysis of Peripheral Blood T cells
Lymphocytes were stained with allophycocyanin-labeled anti-
TCRVβ (H57–597, PharMingen) and fluorescein-isothiocyanate-
labeled anti-TCRVβ8 (F23.1, PharMingen) after the red blood cells
were depleted with Red Blood Cell Lysis Buffer (Sigma, St. Louis,
Missouri). FACS analyses were performed with a Becton Dickinson
FACSCalibur flow cytometer (BD Biosciences).
Animal Experimentation Procedures
All procedures described within were reviewed and approved by
the Animal Experimental Committee at the RIKEN Institute and
were performed in accordance with the RIKEN Guiding Principles
for the Care and Use of Laboratory Animals.
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